Date Filed | Type | Description |
08/16/2023 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Bought 10,000 shares
@ $1.22, valued at
$12.2k
|
|
07/07/2023 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 40,050 shares
@ $0 |
|
01/13/2023 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 33,375 shares
@ $0 |
|
10/14/2022 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 15,575 shares
@ $0 |
|
10/06/2022 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 200,000 shares
@ $0 |
|
08/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/08/2022 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 17,375 shares
@ $0 Granted 32,020 options to buy
@ $3.4, valued at
$108.9k
|
|
12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/05/2021 |
4
| Reynolds Cameron John (President & CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Disposed/sold 125,000 options to buy
@ $4, valued at
$500k
Granted 125,000 options to buy
@ $4, valued at
$500k
Disposed/sold 100,000 options to buy
@ $5, valued at
$500k
Granted 100,000 options to buy
@ $5, valued at
$500k
Disposed/sold 75,000 options to buy
@ $4, valued at
$300k
Granted 75,000 options to buy
@ $4, valued at
$300k
|
|
07/16/2021 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Disposed/sold 55,000 options to buy
@ $4, valued at
$220k
Granted 55,000 options to buy
@ $4, valued at
$220k
|
|
03/01/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/22/2020 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Bought 4,000 shares
@ $2.75, valued at
$11k
|
|
04/15/2020 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 85,000 options to buy
@ $3.6, valued at
$306k
|
|
12/06/2019 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Bought 1,100 shares
@ $4.24, valued at
$4.7k
|
|
02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/21/2018 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Disposed/sold 50,000 options to buy
@ $2.5, valued at
$125k
Disposed/sold 50,000 options to buy
@ $3, valued at
$150k
Granted 50,000 options to buy
@ $2.5, valued at
$125k
Granted 50,000 options to buy
@ $3, valued at
$150k
Disposed/sold 55,000 options to buy
@ $4, valued at
$220k
Granted 55,000 options to buy
@ $4, valued at
$220k
|
|
11/09/2018 |
SC 13D/A
| Reynolds Cameron John reports a 7.2% stake in VolitionRx Limited |
08/17/2018 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Bought 6,500 shares
@ $1.91, valued at
$12.4k
|
|
01/25/2018 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 75,000 options to buy
@ $4, valued at
$300k
|
|
08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/28/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
11/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/24/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/24/2016 |
4/A
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Exercised (in-or-at-the-money) 1,172 shares
@ $2.6, valued at
$3k
|
|
04/22/2016 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Exercised (in-or-at-the-money) 1,172 warrants
@ $2.6, valued at
$3k
Exercised (in-or-at-the-money) 1,429 warrants
@ $2.6, valued at
$3.7k
|
|
04/19/2016 |
4
| Reynolds Cameron John (President and CEO) has filed a Form 4 on VOLITIONRX LTD
Txns:
| Granted 125,000 options to buy
@ $4, valued at
$500k
|
|
08/27/2013 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |